Innate Pharma
Clinical-stage biotech developing immunotherapies for cancer using the innate immune system.
IPH | PA
Overview
Corporate Details
- ISIN(s):
- FR0010331421 (+1 more)
- LEI:
- 9695002Y8420ZB8HJE29
- Country:
- France
- Address:
- 117 AVENUE DE LUMINY, 13009 MARSEILLE
- Website:
- http://www.innate-pharma.com/
- Sector:
- Manufacturing
Description
Innate Pharma is a clinical-stage, oncology-focused biotechnology company that develops immunotherapies for cancer patients. The company's scientific approach is centered on leveraging the innate immune system, particularly Natural Killer (NK) cells, to create novel treatments. Its innovative pipeline is composed of antibody-based therapeutics, including first-in-class monoclonal antibodies, antibody-drug conjugates (ADCs), and multi-specific NK cell engagers based on its proprietary ANKET® platform. Key clinical programs include lacutamab (anti-KIR3DL2), monalizumab (anti-NKG2A) in partnership with AstraZeneca, and a portfolio of NK cell engagers targeting various hematological malignancies and solid tumors.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| 2009-06-15 07:00 |
Innate Pharma SA and its partners announced the operational start of PLATINE, a…
|
English | 51.4 KB | ||
| 2009-06-05 17:50 |
Innate Pharma (Euronext Paris : FR0010331421 – IPH) annonce la tenue de son ass…
|
French | 45.3 KB | ||
| 2009-06-05 17:50 |
Innate Pharma (Euronext Paris: FR0010331421 – IPH) will hold its Annual General…
|
English | 37.1 KB | ||
| 2009-05-29 18:53 |
Innate Pharma (Euronext Paris : FR0010331421 – IPH) présente des résultats prél…
|
French | 54.2 KB | ||
| 2009-05-29 18:53 |
Innate Pharma (Euronext Paris: FR0010331421 – IPH) reports today preliminary re…
|
English | 50.4 KB | ||
| 2009-05-06 20:21 |
Innate Pharma SA : Rapport annuel et Document de Référence 2008
|
French | 1.3 KB | ||
| 2009-05-06 20:20 |
Innate Pharma SA: 2008 Reference Document and Annual Report
|
English | 1.3 KB | ||
| 2009-05-05 17:20 |
Innate Pharma (Euronext Paris : FR0010331421 – IPH) annonce son chiffre d'affai…
|
French | 43.0 KB | ||
| 2009-05-05 17:20 |
Innate Pharma S.A. (Euronext Paris: FR0010331421 – IPH) announces its turnover …
|
English | 42.6 KB | ||
| 2009-04-27 17:50 |
Innate Pharma SA annonce le renforcement de son équipe de management avec la no…
|
French | 33.9 KB | ||
| 2009-04-27 17:50 |
Innate Pharma SA announces today the strengthening of its management team with …
|
English | 34.0 KB | ||
| 2009-04-17 17:51 |
Innate Pharma (Euronext Paris : FR0010331421 – IPH) annonce sa participation pr…
|
French | 35.5 KB | ||
| 2009-04-17 17:51 |
Innate Pharma (Euronext Paris: FR0010331421 – IPH) announces it will participat…
|
English | 35.7 KB | ||
| 2009-02-27 06:50 |
Innate Pharma SA (la « Société »), société biopharmaceutique spécialisée dans l…
|
French | 114.1 KB | ||
| 2009-02-27 06:50 |
Innate Pharma S.A. (the “Company”), a clinical stage biopharmaceutical company …
|
English | 116.8 KB |
Automate Your Workflow. Get a real-time feed of all Innate Pharma filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for Innate Pharma
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for Innate Pharma via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| 2024-01-10 | N/A | Other | Buy | 6,000 | N/A |
| 2024-01-02 | N/A | Other | Buy | 20,000 | N/A |
Peer Companies
